Yale School of Public Health Symposium on tissue imaging mass spectrometry: illuminating phenotypic heterogeneity and drug disposition at the molecular level

• Georgia Charkoftaki,
• Nicholas J. W. Rattray,
• Per E. Andrén,
• Richard M. Caprioli,
• Steve Castellino,
• Mark W. Duncan,
• Richard J. A. Goodwin,
• Kevin L. Schey,
• Sheerin K. Shahidi-Latham,
• Kirill A. Veselkov,
• Caroline H. Johnson,
• Vasilis Vasiliou

Affiliations

Georgia Charkoftaki

Department of Environmental Health Sciences, Yale School of Public Health, Yale University

Nicholas J. W. Rattray

Department of Environmental Health Sciences, Yale School of Public Health, Yale University

Per E. Andrén

Biomolecular Mass Spectrometry Imaging, National Resource for Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University

Richard M. Caprioli

Departments of Biochemistry and the Mass Spectrometry Research Center, Vanderbilt University School of Medicine

Steve Castellino

Department of Bio-Imaging, Platform Science and Technology, GSK

Mark W. Duncan

Biodesix Inc.

Richard J. A. Goodwin

Pathology, Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca

Kevin L. Schey

Departments of Biochemistry and Ophthalmology and Visual Sciences, Vanderbilt University School of Medicine

Sheerin K. Shahidi-Latham

Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc.

Kirill A. Veselkov

Computational and Systems Medicine, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London

Caroline H. Johnson

Department of Environmental Health Sciences, Yale School of Public Health, Yale University

Vasilis Vasiliou

Department of Environmental Health Sciences, Yale School of Public Health, Yale University